Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2013

Mar 20, 2013

30583_dirs_2013-03-20_22fdcbf0-2dc1-4dea-8788-e29bd17aeb30.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2010-03-10

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-03-10 Common Stock M 163888 $22.00 Acquired 224476 Direct
2010-03-10 Common Stock S 163888 $22.5216 Disposed 60588 Direct
2010-05-04 Common Stock G 876 Disposed 59712 Direct
2010-05-05 Common Stock G 1353 Disposed 58359 Direct
2010-11-02 Common Stock G 473 Disposed 57886 Direct
2011-05-04 Common Stock G 1447 Disposed 56439 Direct
2011-11-14 Common Stock G 333 Disposed 56106 Direct
2012-05-01 Common Stock G 920 Disposed 55186 Direct
2012-11-02 Common Stock G 161 Disposed 55025 Direct
2013-01-22 Common Stock G 2675 Disposed 52350 Direct
2010-05-04 Common Stock G 876 Acquired 876 Indirect
2010-05-05 Common Stock G 1353 Acquired 2229 Indirect
2010-11-02 Common Stock G 473 Acquired 2702 Indirect
2011-05-04 Common Stock G 1447 Acquired 4149 Indirect
2011-11-14 Common Stock G 333 Acquired 4482 Indirect
2012-05-01 Common Stock G 920 Acquired 5402 Indirect
2012-11-02 Common Stock G 161 Acquired 5563 Indirect
2013-01-22 Common Stock G 2675 Acquired 8238 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-03-10 Stock Option (right to buy) Common Stock $22.00 M 8335 Disposed 2010-05-08 Common Stock (8335) Direct
2010-03-10 Stock Option (right to buy) Common Stock $22.00 M 155553 Disposed 2010-05-08 Common Stock (155553) Direct

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $22.50 and $22.5262. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: On May 4, 2010 the reportng person gifted 876 shares of Common Stock to his family trust. The reporting person is the trustee.

F3: On May 5, 2010 the reportng person gifted 1353 shares of Common Stock to his family trust. The reporting person is the trustee.

F4: On November 2, 2010 the reportng person gifted 473 shares of Common Stock to his family trust. The reporting person is the trustee.

F5: On May 4, 2011 the reportng person gifted 1447 shares of Common Stock to his family trust. The reporting person is the trustee.

F6: On November 4, 2011 the reportng person gifted 333 shares of Common Stock to his family trust. The reporting person is the trustee.

F7: On May 1, 2012 the reportng person gifted 920 shares of Common Stock to his family trust. The reporting person is the trustee.

F8: On November 2, 2012 the reportng person gifted 161 shares of Common Stock to his family trust. The reporting person is the trustee.

F9: On January 22, 2010 the reportng person gifted 2675 shares of Common Stock to his family trust. The reporting person is the trustee.

F10: Original option grant vested 1/12th on 6/9/2000 and 1/12th on the 9th of every month thereafter.

F11: Original option grant vested 6/48ths on 11/9/2000 and 1/48th on the 9th of every month thereafter.

F12: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.